Platelet transfusions benefit patients with blood cancers

05/9/2013 | Medscape (free registration)

Prophylactic platelet transfusions lowered the risk of significant bleeding events in patients with blood cancers, according to a study in the New England Journal of Medicine. There was a 7% decrease in the proportion of bleeding events among patients who received platelets. "The results of our study support the need for the continued use of prophylaxis with platelet transfusion and show the benefit of such prophylaxis for reducing bleeding," researchers concluded.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC